Strategy

Photo

“Quo vadis, Europe?”

Today, economic success is defined by a different perception and practice of supply capability and supply security. This applies not only to the European trade with chemicals but to the entire chemical value chain.

Photo

Circular Solutions

The path to a sustainable, net-zero future for the chemical industry is paved with challenges – and also opportunities.

Photo

The CDMO/CMO Report

Driven by increased demand in biologic-based drugs, biologic drug substance manufacturing continues to be an active area of investment by contract development and manufacturing organizations/contract manufacturing organizations (CDMOs/CMOs), including several multi-billion large-scale biomanufacturing projects. What companies are expanding, and where do these expansions stand?

Photo

Pharma’s Digital Transformation

Industry experts Michelangelo Canzoneri, Josef Trapl, Wolfgang Winter, Christian Woelbeling, and Thomas Zimmer – all members of ISPE’s Pharma 4.0 guide core team – explain the transformational challenges and critical success factors of the digital Pharma 4.0 journey.

Photo

Chemical Labor Productivity Challenge

The chemical industry faces acute labor shortages because the talent pool is shrinking, but the industry remains heavily reliant on manual work. Therefore, realizing labor productivity potential will be decisive for business continuity and future growth.

Photo

Trying Times and a Wave of Light

In February, industry leaders from 20 industrial sectors presented the ‘Antwerp Declaration for a European Industrial Deal’. The declaration emphasizes industry's dedication to Europe's transformation and outlines urgent needs to enhance Europe's competitiveness, resilience, and sustainability amid challenging economic circumstances.

Photo

Formulating Innovative Concepts

Matthias Hofmann, Group Innovation & Technology Management Director at Azelis, provides an in-depth insight into the company’s innovation activities and the underlying market trends.

Photo

Navigating the Logistics Impact

Cell and gene therapies (CGTs) present a revolutionary approach to the pharmaceutical industry. However, several complexities do arise on a logistical spectrum that diverge from those of traditional pharmaceuticals.

Photo

Generative AI in Chromatographic Analysis

Generative AI can impact the field of chromatography in various innovative ways. However, great care needs to be taken to validate any use of this emerging technology from a technical, quality and regulatory perspective.

Photo

Revolutionizing Green Chemical Production with Ultrasound

Biorefining allows low-carbon feedstocks – such as lignocellulosic biomass – to be processed into intermediate chemicals that can be made into renewable plastics for the automotive industry. Sonichem has developed a breakthrough biorefinery technique that uses ultrasonic energy alongside mild organic acids to fractionate softwood sawdust into hemicellulose sugars, microcrystalline cellulose and high-quality lignin.

Photo

Chemical Distributor Creates Opportunities Through Innovation

On January 1, 2024, Anna Bertona will take on the role of Group CEO, succeeding Hans Joachim Müller, who will retire after serving more than 11 years in that role. Ralf Kempf asked Müller and Bertona about the foundations for the group's continued success and plans for its future strategic direction.

Photo

The Chemical Distribution Industry

Lars Wallstein, IMCD’s Managing Director Germany, who was elected in September as President of FECC – the European Association of Chemical Distributors. He discusses current market trends and the organization's vision for the future of the sector.

Photo

Unleashing CDMO Growth through Effective Pricing

In the rapidly evolving industry of contract development and manufacturing organizations (CDMOs), a well-defined pricing strategy is essential to drive growth and profitability. To stay ahead and participate in the expansion of the market, CDMOs need to transition to a structured value-based pricing approach that considers customer value, complexity, and specific needs.

Photo

Intelligent Engineering for Optimized Pharma Manufacturing

The Covid pandemic and its repercussions have changed the pharmaceutical industry and the healthcare markets. Richard Stedman, the CEO of ACG Engineering, discusses the lessons learned from the global supply chain disruptions and how innovative equipment helps pharma manufacturers overcome the challenges.

Photo

Biosurfactants at Scale

In response to the urgent need for sustainable solutions in the ­surfactants industry, companies like Locus Ingredients are developing environmentally friendly biosurfactants.

Photo

New Biologics and Advanced Therapies

The pharmaceutical market is undergoing a profound transformation, driven by innovation among biologics and advanced therapies (ATs). This shift is not only redefining the treatment landscape but also presenting new opportunities and challenges related to the drug development and manufacturing value chain.

Photo

The Evolution of CDMOs

Contract development and manufacturing organizations (CDMOs) are a crucial part of the life sciences industry. Strangely, despite its current prominence, the CDMO industry is a relatively young one. There have been significant developments over its short lifespan, and it is likely that we see even more growth in the years to come.

532 more articles

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.